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Adenosine modulates the function of a wide variety of cells by engaging
specific receptors on the cell surface . We have recently demonstrated the pres-
ence of adenosine receptors on human neutrophils and shown that engagement
ofadenosine receptors on neutrophilsinhibits superoxideand hydrogen peroxide
production, adherence to endothelial cell monolayers, and killing of cultured
endothelial cells by stimulated neutrophils (1-4) . We and subsequently others
have shown that adenosine inhibits neutrophil function by engaging a specific
subset of adenosine receptors, A2 receptors (2, 5-7) . There are two types of cell
surface adenosine receptors, A, andA2, which are differentiated by their affinity
for adenosine, the order of potency of adenosine analogues and, in many studies,
opposing effects on cellular CAMP metabolism (8-10) . Methylxanthines are
competitive antagonists at both A, and A2 receptors .
We now report the surprising observation that, in marked contrast to the
inhibition of neutrophil functions that we have previously described, adenosine
and itsanalogues promote neutrophil chemotaxis withoutaffecting chemokinesis .
Moreover, adenosine enhances chemotaxis by engaging A2 receptors as indicated
by the order of agonist potency . The paradoxical effect of adenosine A2 receptor
engagement on stimulated neutrophil function, inhibition of superoxide anion
generation but promotion of chemotaxis, suggests that engagement of chemo-
attractant receptors stimulates movement and the respiratory burst by divergent
pathways .
Materials and Methods
Materials . Adenosine, 2-chloroadenosine, Weigert's hematoxylin stain, and human
serum albumin were obtained from Sigma Chemical Co. (St . Louis, MO) . FMLP was
obtained from Vega Biochemicals (Tuscon, AZ) . Ns-(L)-phenylisopropyladenosine (PIA)'
was obtained from Boehringer Mannheim Biochemicals (Indianapolis, IN) . 5'-N-ethylcar-
boxamidoadenosine (NECA) and 8-p-sulfophenyltheophylline(8-PST)were obtained from
Research Biochemicals, Inc . (Wayland, MA) . Agarose was obtained from Bio-Rad Labo-
ratories (Rockville Center, NY) . Zymosan was obtained from ICN Biomedcals, Inc .
This work wassupportedby a generous grantfrom the American Lung Association to Dr. Cronstein
and grants AI-10343, AI-17365, AR-11949, and HL-19721 from the National Institutes of Health .
Dr . Cronstein is the recipient of Clinical Investigator Award KIIAR01490 from the National
Institutes of Health . Address correspondence to B. N . Cronstein, Division of Rheumatology, Dept .
of Medicine, New York University Medical Center, 550 First Avenue, New York, NY 10016 .
' Abbreviations used in this paper:
￿
ECSo, concentration at which 50% effect occurs ; NECA, 5'-N-
ethylcarboxamidoadenosine ; PIA, Ns-L-phenylisopropyladenosine ; 8-PST, 8-p-sulfophenyltheophyl-
line .
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(Cleveland, OH). Nitrocellulose filters were obtained from Millipore Corp. (Bedford,
MA). Tissue culture plates were manufactured by Becton Dickinson Labware (Lincoln
Park, NJ). Medium RPMI 1640 (10X)and sterile NaHC03 solution (7.5%) were obtained
from Gibco Laboratories (Grand Island, NY).
Isolation of Neutrophils.
￿
Human neutrophils were isolated from heparinized whole
blood by centrifugation through Ficoll-Hypaque and sedimentation through dextran (6%
wt/vol) followed by hypotonic lysis of erythrocytes. This procedure allows study of
populations of cells that are 98 ± 2% neutrophils with few contaminating erythrocytes or
platelets (11). Neutrophils were suspended for all of the experiments reported here in
PBS containing magnesium (0.5 mM) and calcium (0.9 mM).
Generation ofZymosan-activated Plasma (ZAP).
￿
Heparinized plasma was incubated with
zymosan (1 mg/ml) for 30 min at 37°C, centrifuged at 1,000 g for 10 min, and the
supernatant was collected and kept on ice until use. For use in chemotactic assays the ZAP
was diluted 1 :10 with incubation buffer (12).
Chemotaxis Assays. Chemotaxis through a filter was measured using the modified
Boyden chamber technique of Zigmond and Hirsch (13) as modified by Axelsson et al .
(14). Neutrophils (6 X 105) were preincubated at 37'C for 10 min with or without
adenosine, adenosine analogues, and/or 8-PST and were then layered onto nitrocellulose
filters (3-,um pore size) overlying chemotactic stimuli (e.g., ZAP, 10%) in an apparatus
described by Axelsson et al. (14; a gift from Pharmacia AB, Uppsala, Sweden). The cells
were then incubated for 35 min at 37°C in a 5% C02 atmosphere, after which the filters
were removed, stained with hematoxylin, and mounted on microscope slides. The extent
of chemotaxis was determined by the leading front technique. Before analysis the original
codings on the slides were covered over and the slides coded so that the reader was
unaware of the condition being examined. Each condition was tested in triplicate or
quadruplicate and leading fronts were measured on three sites per filter. Random
migration of cells towards buffer alone, chemokinesis, was subtracted from the distance
travelled by cells towards the chemotactic stimulus, chemotaxis. Chemotaxis by cells
incubated with adenosine or its analogues is expressed as percent of control chemotaxis.
Data were then fit to a curve by means of the ALLFIT computer program on an Apple
He desktop computer (15; Dr. CarlJohnson, University of Cincinnati College of Medicine,
Cincinnati, OH).
Chemotaxis under agarose was measured by a modification of the method of Nelson et
al. (16). Agarose (2% wt/vol, final) was dissolved in water and then mixed with an equal
volume ofa solution containing RPMI 1640 (2X) and human serum albumin (1 .5% wt/vol)
adjusted to a pH of 7.4 with NaHC03 solution (7.5%, wt/vol). The final solution was
layered onto tissue culture plates and permitted to solidify. A series of three wells 3 mm
apart were cut into the agarose using a template. An aliquot (10 ul) of a neutrophil
suspension (3 X 10'/ml) was placed in the center well and either buffer or a solution of
FMLP was placed in the flanking wells. In preliminary experiments we determined that
the optimal concentration of FMLP for chemotaxis was 10' M. Each condition was
studied in triplicate. The plates were then incubated for 3-4 h at 37°C in a 5% C02
atmosphere, then fixed with a solution of gluteraldehyde (2%) and, after removal of the
agarose, the cells were stained with Weigert's hematoxylin for 2 min. The plates were
studied using an inverted microscope with the image projected onto a screen at a
magnification of x200. Chemotaxis was determined by quantitating the number of cells
contained in an area measuring 25 X 25 mm at varying distances from the origin along
the shortest line connecting the wells containing cellsand chemoattractant. Each box was
assigned a relative value (ranging from 1-6), depending upon its distance from the well
containing the cells. Chemokinesis was determined similarly in the direction of the well
containing buffer. A chemotactic index was calculated by multiplying the cells in each
box by the appropriate weighting figure, calculating the sum of the weighted number of
cells, and then subtracting the sum calculated for chemokinesis from the sum derived for
chemotaxis. The data are expressed as a percentage of control.
Chemokinesis Determinations.
￿
Neutrophil chemokinesis was assessed using the checker-
board analysis technique of Zigmond and Hirsch (13). Buffer or varying concentrations1188
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FIGURE 1. Adenosine enhances neutrophil chemotaxis. Neutro-
phils (6 x 105) were incubated for 10 min at 37°C with or without
adenosine before introduction into the modified Boyden chamber.
Chemotaxis to ZAP (10%) was quantitated as described in Materials
and Methods. Each condition was tested in quadruplicate and
leading fronts were measured on three sites per filter. Migration by
cells incubated with adenosine is expressed as percent control
chemotaxis. Points represent the mean percent control chemotaxis
of three or four separate determinations on cells from different
donors. The mean chemotactic index of control cells in these
experiments was 52 ± 10 Am (t SEM). Dose-response curves were
generated using the ALLFIT program.
FIGURE 2. The adenosine analogues NECA and PIA en-
hance neutrophil chemotaxis. Neutrophils (6 x 105) were
incubated for 10 min at 37°C with or without NECA (O) or
PIA (A) before introduction into the modified Boyden cham-
ber. Chemotaxis to ZAP (10%) was quantitated as described
in Materials and Methods. Each condition was tested in
quadruplicate or triplicate and leading fronts were deter-
mined on three sites per filter. Migration by cells incubated
with NECA or PIA is expressed as percent control chemo-
taxis. Points represent the mean percent control chemotaxis
of separate determinations on cells from different donors
(NECA: n = 3-7 ; PIA: n = 3-4). The mean chemotactic
index of control cells was 52 f 5 and 47 ± 4 Am in the
experiments studying the effect of NECA and PIA, respec-
tively. Dose-response curves were generated using the ALL-
FIT program.
of NECA or 2-chloroadenosine were used on either side of the nitrocellulose filter (3-Am
pore size) in the modified Boyden chamber. The neutrophils (6 X 105) were layered onto
the nitrocellulose filters and migration was assayed as described above. Each condition
was tested in duplicate and leading fronts were measured on three sites per filter.
Calculation ofEC5o ofAdenosine and Analoguesfor Chemotaxis.
￿
Enhancement data were
fitted to a curve by the ALLFIT program on an Apple IIe desktop computer and the
EC5o was calculated for the appropriate curves by means ofthe computer program (15).
Statistical Analysis ofVariance between Dose-Response Curves ofPromotion of Chemotaxis by
Adenosine and its Analogues. F values were derived by use of the following formula: [(SSa
SSb)l(dfadfb)]l(SSbldfb), where SS, is the sum of the squares of the differences when the
curve is forced to conform to external constraints, SSb is the sum of the squares of the
differences of the unconstrained curve, and df is degrees of freedom (17).
Results
Adenosine Promotes Neutrophil Chemotaxis.
￿
In our initial experiments we stud-
ied the effect of varying concentrations of adenosine on neutrophil chemotaxis
stimulated by ZAP. We found that concentrations of adenosine ranging from 1
to 10,000 nM enhanced chemotaxis in a dose-dependent manner (Fig. 1).
Adenosine Enhances Chemotaxis by Engaging A2 Receptors. To determine
whether adenosine promotes chemotaxis by engaging an A, or an A2 receptor,
we next examined the effects of NECA, the most potent A2 agonist, and PIA, a
potent A, agonist, on neutrophil chemotaxis. NECA and PIA both enhanced
chemotaxis in a dose-dependent manner (Fig. 2) with similar maximal enhance-
ment. However NECA was a significantly more potent promoter of chemotaxis
than either PIA or adenosine (p < 0 .01, Fig. 2, Table 1). Adenosine did not
differ significantly from PIA with respect to promotion of chemotaxis. Thus, theTABLE I
Adenosine Enhances Chemotaxis by Engaging an A2 Receptor
Mean chemotaxis, as a percentage of control, was calculated at each
concentration used and the data were fit to a curve by means of the
ALLFIT program. TheEC5o (concentration ofligand required to produce
50% of maximal enhancement ofchemotaxis) and maximal enhancement
figures were calculated from the dose-response curves by means of the
computer program. Thedose-response curves are shown in Figs. 1 and 2
and represent the results of three to seven separate determinations using
the cellsfrom different donors.
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FIGURE 3. 8-PST reverses NECA-mediated enhancement
of chemotaxis. Neutrophils (6 x 105) were incubated for 10
min with buffer, NECA at the indicated concentrations
and/or 8-PST (10pM). Chemotaxis to ZAP (10%)was quan-
titatedas describedin Materialsand Methods. Each condition
was tested in triplicate and leading fronts were determined
on three sites per filter. Chemotaxis is expressed as percent
control chemotaxis. These results are from a single experi-
ment representative of three experiments. The chemotactic
index of control cells in this experiment was 51 ± 3 /m.
order of potency of the adenosine analogues (NECA > PIA ? adenosine) is
identical to that we had previously found for inhibition of superoxide anion
generation and is characteristic ofan adenosine A2 receptor (2).
8-PST Abolishes NECAs Enhancement ofChemotaxis to ZAP.
￿
To provide further
evidence that adenosine and its analogues act at specific adenosine receptors to
enhance chemotaxis, we determined whether 8-PST, a potent adenosine receptor
antagonist, could reverse promotion of chemotaxis by adenosine receptor ago-
nists. Alone, 8-PST (10 AM) affected neither chemotaxis (98 ± 4% ofcontrol, n
= 4) nor chemokinesis (99 ± 5% of control, n = 3). However, 8-PST (10 AM)
completely abolished NECA-mediated (1-100 nM) enhancement of chemotaxis
from a maximal enhancement of 71 ± 8% (concentration of NECA, 100 nM) to
1 ± 2% enhancement (n = 3, Fig. 3). These results are consistent with the
hypothesis that NECA engages an adenosine receptor to enhance chemotaxis.
Adenosine Analogues Do Not Affect Chemokinesis.
￿
Increased random movement
in the presence ofadenosine and its analogues might account for the apparent
promotion of chemotaxis. We therefore performed a checkerboard analysis of
the effects of NECA on random migration ofneutrophils (chemokinesis). NECA
alone did not promote random migration of neutrophils nor did it act as a
chemotactic agent (Table II). Similar results were obtained when the adenosine
Adenosine analogue EC5o
nM
Maximal
enhancement
NECA 00.34 ± 00.26 72 t6
PIA 25.00 ± 18.00 69 ± 11
Adenosine 59.00± 46.00 60 ± 71190
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TABLE II
NECA Does NotPromote Chemokinesis
NECA, at the indicated concentrations, was added to buffer above (with PMNs) and/or below
nitrocellulose filters in a modified Boyden chamber. Thedata are presented as the mean movement
through thefilter (± SEM) in micrometers andrepresentthe measurement of three sites per filter in
two separate filters.
TABLE III
NECA Promotes Chemotaxis to FMLP When Studied Using
Chemotaxis underAgarose
Neutrophils (3 x 105) were placed in wells cut into the agarose in the
presence of buffer or NECA at theindicatedconcentrations. Chemotaxis
to FMLP (10-7 M) was determined as describedin MaterialsandMethods.
These results represent the means of triplicate determinations. Mean
control chemotactic index was 408 and 132 in Exps. 1 and 2, respectively.
receptor agonist 2-chloroadenosine (0.1-100 AM) was used instead of NECA
(data not shown) .
The Adenosine Analogue NECA Also Promotes Neutrophil Chemotaxis under Aga-
rose. To confirm that engagement of adenosine receptors promotes chemotaxis
we studied chemotaxis using a second method, chemotaxis under agarose, and a
second chemotactic agent, FMLP. We found that NECA also promoted chemo-
taxis to FMLP when studied usingthis technique (Table 111). Using this technique
we also did not find any effect of NECA on chemokinesis (data not shown).
Discussion
We and others have previously demonstrated that adenosine and its analogues,
by engaging a specific receptor on human neutrophils, inhibit a variety of
neutrophil functions (1-4, 8-10). Therefore we were surprised when we ob-
served that adenosine promotes rather than inhibits chemotaxis yet does not
affect chemokinesis . Even more surprising is the observation that adenosine
Concentration of NECA
M
Control
Exp. 1
%
chemotaxis
Exp. 2
%
10-4 182 496
10-5 165 526
10-6 175 420
10-' 157 383
10-8 157 578
10-9 ND 245
NECA
above filter 0
NECA
0.01
(AM) below
0.1
filter
1.0 10
Control (10%
ZAP)
AM Am
0.0 22±2 29±2 17±1 20±1 114±4
0.01 23±2 26±2 23±2 18±1
0.1 19±4 23±2 23±2 21±1
1.0 21±1 23±1 18±1
10 .0 23±2 18±1 23±1 21±1ROSE ET AL.
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promotes chemotaxis by engaging A2 adenosine receptors; the same receptors
that, when engaged, inhibit superoxide anion generation. No other agent, to our
knowledge, promotes chemotaxis without affecting chemokinesis yet inhibits
superoxide anion generation.
Adenosine is an autocoid that modulates the behavior of a wide range of
mammalian cell types. Indeed, adenosine or its analogues have previously been
reported to promote sperm motility by a mechanism that may involve cAMP but
is probably not mediated by engagement ofadenosine receptors (18-19). More-
over,adenosineis chemotactic for porcine endothelial cells, againby a mechanism
that is not completely understood (20). The results ofthe studies reported here
and previously suggest that adenosine and its analogues possess the general
property ofpromoting motility. However, adenosine has been demonstrated to
promote motility by a receptor-mediated mechanism only in the neutrophil.
Our demonstration that adenosine and its analogues promote chemotaxis
conflicts with previous reports on the effect ofadenosine on chemotaxis. Nishida
et al. (21) found that concentrations of adenosine and PIA (200-2,000 AM)
much higher than those used here (1 pM to 100 uM) did not affect neutrophil
chemotaxis. Garcia-Castro et al. (22) were also unable to demonstrate that
adenosine affected chemotaxis of rabbit neutrophils directly. The discrepancy
between our results and those reported by Nishida et al. and Garcia-Castro et al.
probably arises from the different methods used to measure chemotaxis by these
groups and us. We have used the leading front technique to assess chemotaxis
through a nitrocellulose filter whereas Nishida et al. (21) and Garcia-Castro et
al. (22) have quantitated the number of cells adherent to the underside of the
nitrocellulose filter. This latter method would underestimate chemotaxis if the
migrating neutrophils did not remain adherent to the filter. We have previously
reported that an adenosine receptor agonist, 2-chloroadenosine, inhibits adher-
ence of stimulated neutrophils to cultured endothelial cells (3). Diminished
adherence of neutrophils to the filters due to adenosine or its analogues could
also contribute to the inability of previous investigators to detect adenosine-
enhanced chemotaxis by quantitating the number of adherent cells on the
underside of the filter. Measurement of chemotaxis by determining the leading
front of neutrophils within the filter after a shorter incubation period avoids
underestimation of chemotaxis due to nonadherence of neutrophils. Further-
more, we confirmed our findings by use ofasecond technique, chemotaxis under
agarose. Finally, wefound thatadenosine and its analoguespromoted chemotaxis
to two different stimuli.
The mechanism by which adenosine receptor engagement inhibits superoxide
anion generation and adherence to endothelial cells but enhances chemotaxis
remains obscure. We have examined several mechanisms by which adenosine
receptor engagementcould alter signal transduction in theneutrophil . Adenosine
does not interfere with stimulated calcium movements in neutrophils. Engage-
ment of adenosine A2 receptors induces an increase in cAMP content in several
cell types(5-7). Weand others have been abletodemonstrate that both adenosine
and NECA induce a rapidly reversible (5 min) increase in neutrophil cAMP
content but only in the presence of a phosphodiesterase inhibitor (9, 23). The
chemoattractant FMLP also elicits increased intracellular cAMP concentrations1192
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in neutrophils. The increment in neutrophil cAMP concentration that follows
stimulation by FMLP is enhanced by NECA in the presence of the phosphodi-
esterase inhibitor (23). However the role ofcAMP in neutrophil motility is only
poorly understood, with some groups reporting that agents that increase cellular
cAMP content promote chemotaxis while others report the opposite (24-30).
Adenosine receptorengagement could lead to alterations in stimulated phospho-
lipid metabolism, activation of intracellular kinases, tyrosinylation of the cyto-
skeleton or other triggering mechanisms for stimulus response coupling in the
neutrophil .
While adenosine is released from many different types of cells or tissue it is
released in greater quantity from damaged cells (1, 30-32). We have found that
adenosine, at concentrations similar to those found in the circulation (33),
possesses the unique ability to promote neutrophil chemotaxis while inhibiting
neutrophils from releasing potentially toxic oxygen metabolites into the extra-
cellular milieu . Thus, adenosine may promote migration of neutrophils to sites
of infection or tissue necrosis yet prevent the migrating neutrophils from dam-
aging healthy tissues en route.
Summary
We have previously (1-4) demonstrated that adenosine, by engaging specific
receptors on the surface of neutrophils, inhibits generation of toxic oxygen
metabolites by activated neutrophils and prevents these activated neutrophils
from injuring endothelial cells. We now report the surprising observation that
engagement of these same neutrophil adenosine receptors promotes chemotaxis
to C5 fragments (as zymosan-activated plasma [ZAP]) or to the bacterial chemo-
attractant FMLP. When chemotaxis was studied in a modified Boyden chamber,
physiologic concentrations of adenosine promoted chemotaxis by as much as
60%. Adenosine receptor analogues, 5'N-ethylcarboxamidoadenosine (NECA)
and N6-phenylisopropyladenosine (PIA), also promoted chemotaxis; the order of
agonist potency was consistent with that of an A2 adenosine receptor
(NECA > PIA ? adenosine). A potent antagonist at adenosine receptors, 8p-
sulfophenyltheophylline (10 /,M), completely reversed NECA enhancement of
chemotaxis but did not affect chemotaxis by itself. Neither NECA nor 2-
chloroadenosine, a nonselective adenosine receptor agonist, alone was chemotac-
tic or chemokinetic by checkerboard analysis. NECA also promoted chemotaxis
quantitated bya different technique, chemotaxis under agarose, to the surrogate
bacterial chemoattractant FMLP. These data suggest that engagement of aden-
osine A2 receptors uniquely modulates neutrophil function so as to promote
migration of neutrophils to sites of tissue damage while preventing the neutro-
phils from injuring healthy tissues en route.
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